跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CYSTADANE betaine 1g/g oral powder bottle - TGA Drug Approval Details
Approvals
/
TGA
/
CYSTADANE betaine 1g/g oral powder bottle
Approved
STANDARD
CYSTADANE betaine 1g/g oral powder bottle
Recordati Rare Diseases Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
a2362ea35eb0726c
Company
Recordati Rare Diseases Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
a2362ea35eb0726c
Product Name
CYSTADANE betaine 1g/g oral powder bottle
Artg Id
57379
Artg Name
CYSTADANE betaine 1g/g oral powder bottle
Sponsor
Recordati Rare Diseases Australia Pty Ltd
Company Detail Path
/organization/recordati-rare-diseases-australia-pty-ltd
Artg Date
1996-09-30
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0d2e755ea548ea8ded81720e29881ec3.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3a75d8d5fbfebc584e895c10e3ae4261.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
a2362ea35eb0726c
Type
Standard
Back to TGA Approvals